Search Results - "Srinivasa, B J"

Afatinib in EGFR TKI-Naïve Patients with Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Pooled Analysis of Three Phase IIIb Studies by Passaro, Antonio, de Marinis, Filippo, Tu, Hai-Yan, Laktionov, Konstantin K., Feng, Jifeng, Poltoratskiy, Artem, Zhao, Jun, Tan, Eng Huat, Gottfried, Maya, Lee, Victor, Kowalski, Dariusz, Yang, Cheng Ta, Srinivasa, BJ, Clementi, Laura, Jalikop, Tejaswini, Huang, Dennis Chin Lun, Cseh, Agnieszka, Park, Keunchil, Wu, Yi-Long

“…BACKGROUNDAfatinib is approved for first-line treatment of patients with epidermal growth factor receptor mutation-positive (EGFRm+) non-small-cell lung cancer…”
Get full text

Prospective Analysis of Patients with Metastatic Breast Cancer receiving Eribulin Mesylate as Second or More Lines of Chemotherapy: An Indian Experience by Srinivasa, BJ, Lalkota, Bhanu Prakash, Badarke, Girish, Hazarika, Diganta, Mohammad, Nasiruddin, Sapkota, Sulav, Khanderia, Mansi, Tousif, D, Rao, Raghavendra, Ram, Amritanshu, Patil, Shekar, Naik, Radheshyam

“…Background: Eribulin mesylate is a non-taxane microtubule inhibitor which can be used after anthracycline and taxane treatment in patients with metastatic…”
Get full text

Role of Intraperitoneal Chemotherapy as the Third-Line Treatment of Epithelial Ovarian Cancer: A Case Report with Literature Review by Devale, Tousif Imdad Mubarak, Srinivasa BJ, Naik, Radheshyam, Kamath, Mangesh, Khanderia, Mansi

“…The intraperitoneal (IP) administration of antineoplastic agents has been proposed as a method to improve the efficacy of therapy of malignant disease…”
Get full text

The role of p53 and ki67 in predicting clinical outcome in breast cancer patients by Lalkota, Bhanu Prakash, Srinivasa, B J, Swamy, Mani V, Hazarika, Diganta, Jeet, B M, Jyothi, K, Ghosh, Mithua, Sayeed, Suhail M, Nasiruddin, Mohammad, Naik, Radheshyam

“…">ki67 may be used as a proliferative index in addition to estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2…”
Get full text

Recurrent squamous cell carcinoma of the skin treated with immunotherapy by Srinivasa, B, Sridhar, P, Lalkota, Bhanu, Tsikai, Nomsa, Niyati, P, Shah, Mansi, Anuradha, S, Roopesh, R, Ramaswamy, Veena, Naik, Radheshyam, Ajaikumar, B

“…Squamous cell carcinoma (SCC) has a good prognosis, while metastatic tumors have aggressive behavior. Immunotherapy has become a standard line of treatment in…”
Get full text

A Phase IIIb Open-Label, Single-Arm Study of Afatinib in EGFR TKI-Naïve Patients with EGFRm+ NSCLC: Final Analysis, with a Focus on Patients Enrolled at Sites in China by Tu, Hai-Yan, Feng, Jifeng, Shi, Meiqi, Zhao, Jun, Wang, Yuyan, Chang, Jianhua, Wang, Jialei, Cheng, Ying, Zhu, Jing, Tan, Eng-Huat, Li, Kai, Zhang, Yiping, Lee, Victor, Yang, Cheng-Ta, Su, Wu-Chou, Lam, David Chi-Leung, Srinivasa, B. J., Rajappa, Senthil, Ho, Ching-Liang, Lam, Kwok Chi, Hu, Yi, Bondarde, Shailesh Arjun, Liu, Xiaoqing, Tian, Yahui, Xue, Zhiyi, Cseh, Agnieszka, Huang, Dennis Chin-Lun, Zhou, Caicun, Wu, Yi-Long

“…Background Afatinib has been shown as a suitable option for the treatment of epidermal growth factor receptor mutation-positive ( EGFR m+) non-small-cell lung…”
Get full text

Reversible Hypopigmentation with Pazopanib by Srinivasa, B J, Lalkota, Bhanu Prakash, Chindar, Pramod S, Naik, Radheshyam

“…Abstract Tablet Pazopanib known to cause Hypo pigmentation and Hyperpigmentation as per various literature reports. We report here a case of reversible…”
Get full text

Acute Pancreatitis Caused by Pemetrexed, Carboplatin, and Gemcitabine in a Patient with Lung Cancer: A Rare Case Report by Kulkarni, Vishal, Srinivasa, BJ, Kiran, PK, Sarathy, Vinu, Swamy, S Shivakumar, Naik, Radheshyam

“…Abstract Drug-induced pancreatitis is reported as one of the less common causes of acute pancreatitis. Many drugs such as sulfonamides, estrogens,…”
Get full text

1474PA combined analysis of two phase IIIb studies of afatinib in EGFR TKI-naïve patients (pts) with EGFR mutation-positive (EGFRm+) NSCLC by de Marinis, F, Tu, H, Laktionov, K K, Feng, J, Poltoratskiy, A, Zhao, J, Egorova, I, Tan, E-H, Gottfried, M, Lee, V, Kowalski, D M, Yang, C-T, Srinivasa, B J, Passaro, A, Clementi, L, Tang, W, Huang, D C-L, Cseh, A, Zhou, C, Wu, Y-L

“…Abstract Background First-line afatinib significantly improved progression-free survival (PFS) in pts with EGFRm+ NSCLC compared with chemotherapy in LUX-Lung…”
Get full text

Recurrent squamous cell carcinoma of the skin treated with immunotherapy by Srinivasa, B J, Sridhar, P S, Lalkota, Bhanu Prakash, Tsikai, Nomsa, Niyati, P S, Shah, Mansi, Anuradha, S, Roopesh, R, Ramaswamy, Veena, Naik, Radheshyam, Ajaikumar, B S

Get full text